Last reviewed · How we verify

NCT05293691

Efficacy of an Online Self-help Program for Negative Affect and Depression

Status unknown NA Last updated 3 May 2022
What this trial tests

NA trial testing Body, Breath & Mind in Depressive Symptoms in 303 participants. Status unknown.

Timeline
25 April 2022
Primary endpoint
1 July 2022
31 March 2023

Quick facts

Lead sponsorUniversity of Witten/Herdecke
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment303
Start date25 April 2022
Primary completion1 July 2022
Estimated completion31 March 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Witten/Herdecke

Who can join

18 and older, any sex, with Depressive Symptoms or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to test Body, breath \& mind (BBM, internet-based self-help program) for its efficacy in reducing depressive symptoms and improving quality of life. BBM combines methods of value-oriented behavioral activation with exercises from the Chinese healing practice Qi Gong,. BBM will be compared to an active control treatment (moodgym) and a waiting list control group. We expect significant differences to the waiting list control group. In comparison to the active control treatment we expect no significant differences.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depressive Symptoms

Currently open trials in the same condition.

Other University of Witten/Herdecke trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05293691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing